The Research Report on “Influenza Diagnostics Market” 2019 report includes every aspect of the Influenza Diagnostics industry along with the progress performance. Influenza Diagnostics Market report presents an analysis of market size, share, and growth, trends, and price structure, statistical and detailed data of the Influenza Diagnostics industry. Additionally, Influenza Diagnostics Market 2019 research report offers key analysis on the industry status of the Influenza Diagnostics producers with market size, growth, share, trends as well as business price structure.
The Influenza Diagnostics Market report is a professional and detailed study on the Influenza Diagnostics business. Influenza Diagnostics market to predict future market directions between the forecast periods from 2019 to 2024 providing you with vital data for your business decisions.
Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/13999593
Scope of the Report:
Influenza Diagnostics Report Also Covers Offer for New Project Includes:
- Market Entry Strategies
- Countermeasures of Economic Impact
- Marketing Channels
- Feasibility Studies of New Project Investment
- Research Conclusions of the Influenza Diagnostics Industry
The report provides key statistics on the market status of the Influenza Diagnostics Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Influenza Diagnostics.
Enquire Before Purchasing this Report – https://www.industryresearch.co/enquiry/pre-order-enquiry/13999593
Influenza Diagnostics Market Report Also Covers Marketing Strategy Analysis, Top Manufacturers:
Key Market Trends:
Rapid Influenza Diagnostic Test (RIDT) is Expected to hold its Highest Market Share in the Test Type Segment
In the test type segment of the influenza diagnostics market, among all traditional diagnostic tests, the rapid influenza diagnostic test (RIDT) is believed to have the largest market size and is expected to witness a CAGR of 6.87% during the forecast period.
Rapid influenza diagnostic tests (RIDTs) are immunoassays, which help to identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens and qualitatively provide the results. It can diagnose patients, who are present with influenza-like illness, mainly if it is performed within the first four days of the onset of symptoms.
The rising popularity of RIDT is due to the benefits of faster result and simple usage. Some of the RIDTs are also approved for office/bedside use as well. The RIDT segment is also expected to witness rapid growth, as a result of their common usage in point-of-care settings.
However, one of the major drawback associated with RIDT is that it gives false negative results, due to its low to moderate sensitivities (50-70%). Healthcare policymakers began to recognize the impact of its low sensitivity in 2009, when the novel H1N1 influenza epidemic occurred.
North America Dominates the Market and is Expected to do the Same in the Forecast Period
North America currently dominates the market for influenza diagnostics and is expected to continue its stronghold for a few more years.
As per data published by the Centers for Disease Control and Prevention (CDC), RIDTs are commonly available across the region. The reason behind the wide availability of the test is the reduced time span needed to generate results. RIDT can yield results in 15 minutes. With increasing influenza-associated hospitalization and pediatric deaths and the interest of government organizations to better manage the disease, the North American influenza diagnostics market is expected to grow in the future.
Purchase this Report (Price 4250 USD for Single User License) – https://www.industryresearch.co/purchase/13999593
Detailed TOC of Influenza Diagnostics Market Report are:
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Influenza and Related Chronic Diseases
4.2.2 Growth in Research Funding for Influenza Diagnostics
4.2.3 Rising Demand for Early Diagnosis and Control of Influenza
4.3 Market Restraints
4.3.1 Product Safety and High Cost of Development
4.3.2 Stringent Government Regulations
4.3.3 Variability in Sensitivity and Specificity among Influenza Diagnostic Tests
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Test Type
5.1.1 Traditional Diagnostic Test
220.127.116.11 Rapid Influenza Diagnostic Test (RIDT)
18.104.22.168 Viral Culture
22.214.171.124 Direct Fluorescent Antibody (DFA) Test
126.96.36.199 Serological Assay
5.1.2 Molecular Diagnostic Assay
188.8.131.52 Nucleic Acid Sequence-based Amplification (NASBA) Test
184.108.40.206 Loop-mediated Isothermal Amplification-based Assay (LAMP)
220.127.116.11 Simple Amplification-based Assay (SAMBA)
18.104.22.168 Other Molecular Diagnostic Assays
5.2 End User
5.2.2 Research Laboratory
5.2.3 Other End Users
5.3.1 North America
22.214.171.124 United States
126.96.36.199 United Kingdom
188.8.131.52 Rest of Europe
184.108.40.206 South Korea
220.127.116.11 Rest of Asia-Pacific
5.3.4 Middle East & Africa
18.104.22.168 South Africa
22.214.171.124 Rest of Middle East & Africa
5.3.5 South America
126.96.36.199 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.2 Becton, Dickinson and Company
6.1.3 Coris BioConcept
6.1.4 DiaSorin SpA
6.1.5 F. Hoffmann-La Roche Ltd
6.1.6 Luminex Corporation
6.1.7 Meridian Bioscience Inc.
6.1.8 Quidel Corporation
6.1.9 Sekisui Diagnostics
6.1.10 Thermo Fisher Scientific Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Name: Ajay More
Phone: US +14242530807/ UK +44 20 3239 8187
Email: [email protected]
Our Other Reports: